Spironolactone (aldactone) bodies: concentric lamellar formations in the adrenal cortices of patients treated with spironolactone.
D000311:Adrenal Glands / Q000473:pathology*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003594:Cytoplasmic Granules / Q000032:analysis / Q000378:metabolism; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000473:pathology*; D006338:Heart Neoplasms / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008566:Membranes; D008854:Microscopy, Electron; D008875:Middle Aged; D008901:Mineralocorticoids / Q000096:biosynthesis; D010743:Phospholipids / Q000032:analysis; D013148:Spironolactone / Q000627:therapeutic use*
D008901:Mineralocorticoids; D010743:Phospholipids; D013148:Spironolactone